DAFNA Capital Management as of June 30, 2021
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 84 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis Com New (STXS) | 27.6 | $132M | 14M | 9.64 | |
| Fate Therapeutics (FATE) | 5.7 | $27M | 314k | 86.79 | |
| Dicerna Pharmaceuticals | 4.0 | $19M | 511k | 37.32 | |
| Blueprint Medicines (BPMC) | 3.8 | $18M | 208k | 87.96 | |
| Theravance Biopharma (TBPH) | 2.2 | $11M | 732k | 14.52 | |
| Morphic Hldg (MORF) | 2.2 | $10M | 182k | 57.39 | |
| Translate Bio | 2.2 | $10M | 377k | 27.54 | |
| Sage Therapeutics (SAGE) | 2.0 | $9.7M | 170k | 56.81 | |
| Biohaven Pharmaceutical Holding | 1.9 | $9.1M | 94k | 97.08 | |
| Dex (DXCM) | 1.9 | $9.0M | 21k | 427.00 | |
| Affimed Therapeutics B V | 1.7 | $8.2M | 965k | 8.50 | |
| Arena Pharmaceuticals Com New | 1.7 | $8.2M | 120k | 68.20 | |
| Nurix Therapeutics (NRIX) | 1.7 | $8.1M | 306k | 26.53 | |
| Xenon Pharmaceuticals (XENE) | 1.6 | $7.6M | 407k | 18.62 | |
| AtriCure (ATRC) | 1.5 | $7.3M | 92k | 79.33 | |
| Neurocrine Biosciences (NBIX) | 1.5 | $7.2M | 74k | 97.32 | |
| Ideaya Biosciences (IDYA) | 1.5 | $7.0M | 332k | 20.99 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 1.5 | $7.0M | 1.0M | 6.74 | |
| Ishares Tr Nasdaq Biotech Etf (IBB) | 1.4 | $6.7M | 41k | 163.64 | |
| Revolution Medicines (RVMD) | 1.4 | $6.7M | 210k | 31.74 | |
| Cardiovascular Systems | 1.3 | $6.4M | 150k | 42.65 | |
| F-star Therapeutics | 1.3 | $6.1M | 714k | 8.59 | |
| Karuna Therapeutics Ord | 1.3 | $6.0M | 53k | 113.98 | |
| Galapagos Nv Spon Adr (GLPG) | 1.1 | $5.4M | 78k | 68.89 | |
| Otonomy | 1.1 | $5.3M | 2.4M | 2.23 | |
| Luminex Corporation | 1.1 | $5.1M | 139k | 36.80 | |
| Aerie Pharmaceuticals | 1.0 | $4.6M | 289k | 16.01 | |
| Cara Therapeutics (CARA) | 0.9 | $4.5M | 315k | 14.27 | |
| Accuray Incorporated (ARAY) | 0.9 | $4.3M | 942k | 4.52 | |
| Neuronetics (STIM) | 0.9 | $4.1M | 254k | 16.02 | |
| Adicet Bio (ACET) | 0.8 | $3.9M | 376k | 10.29 | |
| Turning Point Therapeutics I | 0.8 | $3.7M | 48k | 78.01 | |
| Radius Health Note 3.000% 9/0 (Principal) | 0.8 | $3.7M | 4.0M | 0.93 | |
| Venus Concept | 0.8 | $3.7M | 1.2M | 3.11 | |
| Mereo Biopharma Group Ads (MREO) | 0.7 | $3.6M | 1.1M | 3.17 | |
| Merus N V (MRUS) | 0.7 | $3.3M | 158k | 21.07 | |
| Arcus Biosciences Incorporated (RCUS) | 0.7 | $3.3M | 120k | 27.46 | |
| Redhill Biopharma Sponsored Ads | 0.7 | $3.1M | 456k | 6.88 | |
| Fs Development Corp Ii Com Cl A | 0.6 | $3.0M | 300k | 9.98 | |
| Hookipa Pharma Inc equity (HOOK) | 0.6 | $3.0M | 322k | 9.16 | |
| Viking Therapeutics (VKTX) | 0.6 | $2.7M | 447k | 5.99 | |
| Syndax Pharmaceuticals (SNDX) | 0.5 | $2.5M | 148k | 17.17 | |
| Natus Medical | 0.5 | $2.5M | 96k | 25.98 | |
| Century Therapeutics (IPSC) | 0.5 | $2.3M | 80k | 29.34 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.5 | $2.2M | 603k | 3.72 | |
| Aslan Pharmaceuticals Ads | 0.5 | $2.2M | 678k | 3.30 | |
| Cymabay Therapeutics | 0.5 | $2.2M | 510k | 4.36 | |
| 89bio (ETNB) | 0.5 | $2.2M | 117k | 18.70 | |
| Brainway Sponsored Ads (BWAY) | 0.4 | $2.0M | 200k | 10.20 | |
| Mei Pharma Com New | 0.4 | $1.8M | 641k | 2.85 | |
| Cogent Biosciences (COGT) | 0.4 | $1.8M | 224k | 8.11 | |
| Inflarx Nv (IFRX) | 0.4 | $1.8M | 600k | 2.97 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $1.8M | 100k | 17.56 | |
| Mersana Therapeutics (MRSN) | 0.4 | $1.7M | 128k | 13.58 | |
| Kura Oncology (KURA) | 0.4 | $1.7M | 84k | 20.86 | |
| Compugen Ord (CGEN) | 0.3 | $1.7M | 202k | 8.28 | |
| Athira Pharma (ATHA) | 0.3 | $1.6M | 161k | 10.24 | |
| Sutro Biopharma (STRO) | 0.3 | $1.6M | 85k | 18.59 | |
| Bolt Biotherapeutics (BOLT) | 0.3 | $1.5M | 100k | 15.46 | |
| Kadmon Hldgs | 0.3 | $1.5M | 395k | 3.87 | |
| Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 0.3 | $1.5M | 1.5M | 1.00 | |
| Conformis | 0.3 | $1.5M | 1.3M | 1.15 | |
| Lava Therapeutics Bv SHS (LVTX) | 0.3 | $1.5M | 136k | 10.88 | |
| Nextcure (NXTC) | 0.3 | $1.5M | 184k | 8.03 | |
| Harpoon Therapeutics | 0.3 | $1.5M | 105k | 13.87 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $1.5M | 61k | 23.96 | |
| Infinity Pharmaceuticals (INFIQ) | 0.3 | $1.4M | 459k | 2.99 | |
| Kinnate Biopharma (KNTE) | 0.3 | $1.3M | 54k | 23.28 | |
| Iveric Bio | 0.2 | $1.1M | 180k | 6.31 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.2 | $1.1M | 244k | 4.34 | |
| Alpine Immune Sciences (ALPN) | 0.2 | $1.0M | 113k | 9.00 | |
| Inogen (INGN) | 0.2 | $978k | 15k | 65.20 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 0.2 | $939k | 7.1k | 131.57 | |
| Rti Biologics | 0.2 | $806k | 580k | 1.39 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $803k | 13k | 63.21 | |
| Larimar Therapeutics (LRMR) | 0.2 | $756k | 77k | 9.82 | |
| Vascular Biogenics | 0.2 | $734k | 307k | 2.39 | |
| Masimo Corporation (MASI) | 0.2 | $727k | 3.0k | 242.33 | |
| Genfit S A Ads (GNFT) | 0.1 | $716k | 189k | 3.80 | |
| Ngm Biopharmaceuticals (NGM) | 0.1 | $601k | 31k | 19.70 | |
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $545k | 5.6k | 97.32 | |
| Radius Health Com New | 0.1 | $264k | 15k | 18.21 | |
| Scpharmaceuticals (SCPH) | 0.0 | $238k | 39k | 6.12 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.0 | $156k | 8.0k | 19.50 |
